EXPRESSION AND REGULATION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) ANDIGF-BINDING PROTEIN MESSENGER-RIBONUCLEIC-ACID LEVELS IN TISSUES OF HYPOPHYSECTOMIZED RATS INFUSED WITH IGF-I AND GROWTH-HORMONE
Ma. Gostelipeter et al., EXPRESSION AND REGULATION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) ANDIGF-BINDING PROTEIN MESSENGER-RIBONUCLEIC-ACID LEVELS IN TISSUES OF HYPOPHYSECTOMIZED RATS INFUSED WITH IGF-I AND GROWTH-HORMONE, Endocrinology, 135(6), 1994, pp. 2558-2567
The expression and regulation of insulin-like growth factor-I (IGF-I)
and IGF-binding protein-2 (IGFBP-2), -3, -4, and -5 messages were stud
ied in liver, kidney, spleen, thymus, heart, brain, skeletal muscle, t
estes, and epididymal (white) adipose tissue (WAT) from hypophysectomi
zed rats infused with saline, recombinant human (rh) IGF-I, or rhGH an
d compared with tissue messenger RNA (mRNA) levels in age-matched norm
al rats. The IGF-I message was present in all of these tissues. It was
most abundant in liver and WAT, but was barely detectable in kidney,
brain, and thymus. GH dependence was most pronounced in liver, skeleta
l muscle, and WAT and less so in heart, testes, kidney, spleen, and th
ymus. The IGF-I message in brain was not influenced by hypophysectomy.
IGF-I infusion induced a small increase in its own mRNA in skeletal m
uscle and WAT, whereas it decreased its own message in liver. IGFBPs w
ere expressed in a tissue-specific manner; IGFBP-2 mRNA was most abund
ant in testes and hypophysectomized liver, IGFBP-3 mRNA was most abund
ant in spleen, kidney, WAT, and liver, IGFBP-4 mRNA was most abundant
in liver, and IGFBP-5 mRNA was most abundant in kidney, WAT, and skele
tal muscle. After hypophysectomy, significant decreases in IGFBP expre
ssion were observed in liver (except IGFBP-2), skeletal muscle, brain,
WAT (except IGFBP-4), and testes (except IGFBP-2), in contrast to hea
rt, kidney, spleen, and thymus. GH infusion did not affect IGFBP-2 mRN
A levels in liver (in contrast to IGF-I infusion) or brain. Like GH, I
GF-I normalized IGFBP-3 mRNA levels in liver, but, in contrast to GH,
had no effect on IGFBP-5 mRNA in WAT. It was considerably less effecti
ve than GH in raising IGFBP-5 mRNA levels in skeletal muscle. Thus, GH
infusion can exert different effects on IGF-I and IGFBP expression th
an infused rhIGF-I. Differences may be due to direct actions of GH at
the tissue level, including auto/paracrine effects of locally produced
IGF-I.